Related Experiment Video
Updated: May 20, 2025

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
Post-COVID-19 Pandemic Sequelae in Liver Diseases
1Department of Life Science, Health and Health Professions, Link Campus University, 00165 Roma, Italy.
The COVID-19 pandemic can cause long-term liver damage, including worsening existing liver conditions or causing new ones like fatty liver disease. This review examines the mechanisms and consequences of these hepatic manifestations.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- COVID-19 is linked to adverse liver outcomes, particularly in patients with pre-existing liver conditions.
- Long COVID-19 can manifest as hepatic issues, including exacerbations of chronic liver diseases or new-onset liver conditions.
- The virus utilizes ACE2 and TMPRSS2 receptors, present in liver cells, contributing to hepatic damage.
Purpose of the Study:
- To review the pathophysiological mechanisms of COVID-19-related liver and hepatobiliary damage.
- To explore the impact of COVID-19 on liver inflammation, fibrosis, metabolic-associated fatty liver disease (MASLD), and metabolic dysfunction-associated steatohepatitis (MASH).
- To analyze the short- and long-term sequelae of COVID-19 on liver health.
Main Methods:
- Literature search conducted on the PubMed database.
- Focus on studies published in English.
- Review of pathophysiological mechanisms, clinical implications, and sequelae of COVID-19 on the liver.
Main Results:
- Post-COVID-19 liver findings include steatosis and necroinflammation.
- Alterations in inflammation, cytolysis, and cholestasis indices are observed.
- Increased risk of hepatobiliary pathologies, including secondary biliary cholangitis and worsening of MASLD, is noted.
Conclusions:
- COVID-19 poses significant short- and long-term risks to liver health.
- Understanding these hepatic manifestations is crucial for managing patients post-COVID-19.
- Further research is needed to fully elucidate the long-term impact on liver diseases, especially MASLD and MASH.
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Acute Pancreatitis II: Clinical Manifestations and Management
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...

